NoticeInformation only. Not medical advice. Nothing here is a recommendation to use any substance. Read full disclaimer
10 items
Oprah Daily
The provided excerpt repeats only the Oprah Daily headline and is too thin for a substantive summary. The headline says peptide injections are about to become easier to access and attributes concerns about the supporting science to doctors.
ClinicalTrials.gov: peptide AND aging
A ClinicalTrials.gov listing describes a recruiting phase 2 study comparing adalimumab with placebo in people with idiopathic REM sleep behavior disorder. The study will assess whether adalimumab can reduce or prevent progression of synuclein-related neurodegeneration, using changes in a Parkinson disease-related imaging pattern as its primary endpoint.
ClinicalTrials.gov: peptide AND aging
A recruiting study listed on ClinicalTrials.gov will evaluate whey protein’s effects on glucose control in adults aged 70–90 with type 2 diabetes. The placebo-controlled, partial crossover trial will assess glucose excursions over 7-day periods; the excerpt reports no results.
ClinicalTrials.gov: peptide AND aging
A ClinicalTrials.gov listing describes a trial comparing ketone monoester plus protein with protein alone after resistance exercise in older trained males. The trial is not yet recruiting and will assess phenylalanine metabolism and measures of protein breakdown; no results are reported.
FDA press releases
The FDA granted accelerated approval for a new use of Jemperli (dostarlimab-gxly) in certain patients with locally advanced rectal cancer. The agency says the immunotherapy may allow some patients to avoid chemotherapy, radiation and surgery.
ClinicalTrials.gov: peptide AND aging
A recruiting trial listed on ClinicalTrials.gov will study Adapted Argentine Tango for chemotherapy-induced neuropathy in breast cancer survivors. The listing states that up to 80% of these survivors experience neuropathy and describes an intervention targeting motor control, symptoms, and treatment participation.
ClinicalTrials.gov: peptide AND aging
A ClinicalTrials.gov listing describes a planned 16-week randomized trial of resistance training, whole-body electrical stimulation, and dietary protein guidance in 36 older adults with overweight or obesity. The study is not yet recruiting and will assess body composition, physical function, and quality of life; no peptide intervention is described.
ClinicalTrials.gov: peptide AND aging
A ClinicalTrials.gov listing reports that a study of mother-of-pearl nutritional supplementation for preventing post-menopausal osteoporosis is recruiting. The excerpt describes the need for prevention but provides no study results or specific peptide information.
FDA press releases
The FDA approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for children with congenital pulmonary valve disease. The announcement describes it as the first heart valve designed to grow with children.
FDA press releases
The FDA announced approval of Fayuvi (rebisufligene etisparvovec-hopf), a gene therapy for pediatric patients with Sanfilippo syndrome type A. The agency describes it as the first treatment for the condition, also known as mucopolysaccharidosis type IIIA (MPS IIIA).